Pharmaceuticals in South Africa

Pharmaceuticals in South Africa


  • Products Id :- OHMF4096
  • |
  • Pages: 40
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pharmaceuticals in South Africa

Summary

Pharmaceuticals in South Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the South Africa pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The South African pharmaceuticals market had total revenues of USD 6.6bn in 2017, representing a compound annual growth rate (CAGR) of 5% between 2013 and 2017.

- Generics will continue to be a popular choice in South Africa given its aging population and increased education to the public on the importance of a proactive approach to their own healthcare.

- The government is attempting to increase the growth rate of the pharmaceutical industry. The introduction of the South African Health Products Regulatory Authority (SAHPRA) in June 2017 has been part of this effort.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in South Africa

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Africa

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the South Africa pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the South Africa pharmaceuticals market by value in 2017?

- What will be the size of the South Africa pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the South Africa pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in South Africa's pharmaceuticals market?



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 16

New entrants 18

Threat of substitutes 20

Degree of rivalry 21

Leading Companies 23

Adcock Ingram Holdings Ltd 23

Aspen Pharmacare Holdings Ltd 26

Novartis AG 29

Sanofi SA 32

Macroeconomic Indicators 35

Country data 35

Methodology 37

Industry associations 38

Related MarketLine research 38

Appendix 39

About MarketLine 39

List of Figures

Figure 1: South Africa pharmaceuticals market value: USD billion, 2013-17

Figure 2: South Africa pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: South Africa pharmaceuticals market share: % share, by value, 2017

Figure 4: South Africa pharmaceuticals market value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in South Africa, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in South Africa, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in South Africa, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2017

Figure 11: Adcock Ingram Holdings Ltd: revenues & profitability

Figure 12: Adcock Ingram Holdings Ltd: assets & liabilities

Figure 13: Aspen Pharmacare Holdings Ltd: revenues & profitability

Figure 14: Aspen Pharmacare Holdings Ltd: assets & liabilities

Figure 15: Novartis AG: revenues & profitability

Figure 16: Novartis AG: assets & liabilities

Figure 17: Sanofi SA: revenues & profitability

Figure 18: Sanofi SA: assets & liabilities

List of Tables

Table 1: South Africa pharmaceuticals market value: USD billion, 2013-17

Table 2: South Africa pharmaceuticals market geography segmentation: USD billion, 2017

Table 3: South Africa pharmaceuticals market share: % share, by value, 2017

Table 4: South Africa pharmaceuticals market value forecast: USD billion, 2017-22

Table 5: Adcock Ingram Holdings Ltd: key facts

Table 6: Adcock Ingram Holdings Ltd: key financials (USD )

Table 7: Adcock Ingram Holdings Ltd: key financials (ZAR)

Table 8: Adcock Ingram Holdings Ltd: key financial ratios

Table 9: Aspen Pharmacare Holdings Ltd: key facts

Table 10: Aspen Pharmacare Holdings Ltd: key financials (USD )

Table 11: Aspen Pharmacare Holdings Ltd: key financials (ZAR)

Table 12: Aspen Pharmacare Holdings Ltd: key financial ratios

Table 13: Novartis AG: key facts

Table 14: Novartis AG: key financials (USD )

Table 15: Novartis AG: key financial ratios

Table 16: Sanofi SA: key facts

Table 17: Sanofi SA: key financials (USD )

Table 18: Sanofi SA: key financials (EUR)

Table 19: Sanofi SA: key financial ratios

Table 20: South Africa size of population (million), 2013-17

Table 21: South Africa gdp (constant 2005 prices, USD billion), 2013-17

Table 22: South Africa gdp (current prices, USD billion), 2013-17

Table 23: South Africa inflation, 2013-17

Table 24: South Africa consumer price index (absolute), 2013-17

Table 25: South Africa exchange rate, 2013-17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 350 INR 25144
Site License
USD 700 INR 50288
Corporate User License
USD 1050 INR 75432

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com